Cytotoxic and enzyme inhibitory potential of two potentilla species (P. speciosa L. and P. reptans Willd.) and their chemical composition
dc.contributor.author | Uysal, S | |
dc.contributor.author | Zengin, G | |
dc.contributor.author | Locatelli, M | |
dc.contributor.author | Bahadori, MB | |
dc.contributor.author | Mocan, A | |
dc.contributor.author | Bellagamba, G | |
dc.contributor.author | Luca, ED | |
dc.contributor.author | Mollica, A | |
dc.contributor.author | Aktumsek, A | |
dc.date.accessioned | 2018-08-26T08:51:21Z | |
dc.date.available | 2018-08-26T08:51:21Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53354 | |
dc.description.abstract | In this work, the biological and chemical fingerprints of three extracts (ethyl acetate, methanol, and water) from two Potentilla species (Potentilla reptans and P. speciosa) were investigated. Antioxidant, enzyme inhibitory, and cytotoxic activities were performed for the biological fingerprint. For the chemical characterization, total bioactive components, and individual phenolic components were determined using photometric and HPLC methods, respectively. The main identified phenolic compounds in these extracts were rutin and catechin. Methanol and water extracts contained the highest total phenolic and flavonoid content. The results of antioxidant assays showed that methanol and water extracts displayed higher antioxidant activity compared to the ethyl acetate extract. Generally, methanol and water extracts exhibited higher biological activities correlated with higher levels the bioactive components. For P. speciosa, the methanol extract exhibited the highest enzyme inhibitory activity (except BChE inhibitory activity). P. reptans exhibited also high antiproliferative activity against MCF-7 cells whilst P. speciosa had weak to moderate activity against both of A549 and MCF-7 cell lines. The results suggest that Potentilla species could be potential candidates for developing new phyto-pharmaceuticals and functional ingredients. é 2017 Uysal, Zengin, Locatelli, Bahadori, Mocan, Bellagamba, De Luca, Mollica and Aktumsek. | |
dc.language.iso | English | |
dc.relation.ispartof | Frontiers in Pharmacology | |
dc.subject | 3 hydroxybenzoic acid | |
dc.subject | 4 hydroxybenzoic acid | |
dc.subject | acetic acid ethyl ester | |
dc.subject | benzoic acid | |
dc.subject | catechin | |
dc.subject | chlorogenic acid | |
dc.subject | cinnamic acid | |
dc.subject | coumarin | |
dc.subject | cytotoxic agent | |
dc.subject | epicatechin | |
dc.subject | ferulic acid | |
dc.subject | flavanoid | |
dc.subject | gallic acid | |
dc.subject | methanol | |
dc.subject | naringenin | |
dc.subject | para coumaric acid | |
dc.subject | phenol | |
dc.subject | plant extract | |
dc.subject | Potentilla reptans extract | |
dc.subject | Potentilla speciosa extract | |
dc.subject | quercetin | |
dc.subject | rutoside | |
dc.subject | saponin | |
dc.subject | sinapic acid | |
dc.subject | syringic acid | |
dc.subject | triterpenoid | |
dc.subject | unclassified drug | |
dc.subject | vanillic acid | |
dc.subject | water | |
dc.subject | A-549 cell line | |
dc.subject | antineoplastic activity | |
dc.subject | antioxidant activity | |
dc.subject | antioxidant assay | |
dc.subject | antiproliferative activity | |
dc.subject | Article | |
dc.subject | chemical composition | |
dc.subject | controlled study | |
dc.subject | drug cytotoxicity | |
dc.subject | enzyme inhibition | |
dc.subject | high performance liquid chromatography | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | MCF-7 cell line | |
dc.subject | phytochemistry | |
dc.subject | Potentilla | |
dc.subject | Potentilla reptans | |
dc.subject | Potentilla speciosa | |
dc.title | Cytotoxic and enzyme inhibitory potential of two potentilla species (P. speciosa L. and P. reptans Willd.) and their chemical composition | |
dc.type | Article | |
dc.citation.volume | 8 | |
dc.citation.issue | MAY | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.3389/fphar.2017.00290 |